«« | Feb 2008 | »» | ||||
S | M | T | W | T | F | S |
1
|
2
|
|||||
3 |
4
|
5
|
6 |
7
|
8
|
9 |
10 |
11
|
12
|
13
|
14
|
15
|
16
|
17 |
18
|
19
|
20
|
21
|
22 | 23 |
24 | 25 | 26 | 27 | 28 | 29 |
Reuters:
Antidepressants effective treatment options for OCD
Fox News:
Hopelessness often lingers after depression lifts
KOCO-5, Oklahoma City:
Primary Psychiatry. 2006;13(10):32-35
Dr. Arnold is currently a scientist-track investigator and staff psychiatrist at the Hospital for Sick Children in Toronto, Canada. His research activities focus on the molecular genetics of early-onset obsessive-compulsive disorder (OCD). Dr. Arnold's clinical work involves the assessment and treatment of children with OCD and obsessive-compulsive spectrum disorders. He has received numerous awards in recognition for his work, including the Career Development Award of the Anxiety Disorders Association of America and the Government of Ontario/Gregory M. Brown Graduate Scholarship in Science and Technology.
How do you conceptualize obsessive-compulsive disorder (OCD)?
OCD can be conceptualized as a single disorder with various presentations, as separate disorders with similar presentations, or as a spectrum disorder. The description of OCD in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, (DSM-IV)1 has been helpful in the development of treatments that have been somewhat successful. However, researchers and clinicians working with OCD have started to define it a little differently. The tendency lately has been toward thinking of it as a group of disorders with similar manifestations. However, the exact way to think about OCD is a matter of some controversy and discussion in the field.
More...
© 2006 Primary Psychiatry
tags: obsessive compulsive disorder ocd glutamate transporter genetics
links: digg this del.icio.us technorati reddit